Wednesday, June 10, 2026
🇺🇸 FDA

P0 · Therapeutic area intelligence

Infectious disease patent intelligence

Antiviral, antibacterial, and vaccine-related pharmaceutical patents.

Patents
1,492

Quick answer

1,492 US pharmaceutical patents in our index match Infectious disease title keywords (A61K/A61P). Cross-link to related drug therapeutic-area hubs and company patent portfolios for full IP context.

  1. US 10548916

    Composition comprising neoagarooligosaccharide as active ingredient, for prevention or treatment of sepsis or septic shock

    DYNEBIO INC. · Granted Tue Feb 04 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 30 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 10548948

    Methods of treating fungal infections

    United States of America as represented by the Secretary of the Air Force · Granted Tue Feb 04 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 30 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 10544085

    Oils having antibacterial activity

    The United States of America, as represented by the Secretary of Agriculture · Granted Tue Jan 28 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 23 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 10543257

    Lentiviral vector for treating hemoglobin disorders

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Jan 28 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 23 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 10538532

    Hepatitis B antiviral agents

    Enanta Pharmaceuticals, Inc. · Granted Tue Jan 21 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 16 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 10537528

    Methods of treating non-alcoholic steatohepatitis (NASH) using cysteamine compounds

    The Regents of the University of California · Granted Tue Jan 21 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 16 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 10525106

    Angiopoietin-based interventions for treating cerebral malaria

    REGENERON PHARMACEUTICALS, INC. · Granted Tue Jan 07 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 02 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 10525123

    Methods for inducing an immune response against human immunodeficiency virus infection in subjects undergoing antiretroviral treatment

    The Government of the United States, as represented by the Secretary of the Army · Granted Tue Jan 07 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 02 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 10517920

    Antibacterial peptide and method of treatment using the antibacterial peptide

    UNITED ARAB EMIRATES UNIVERSITY · Granted Tue Dec 31 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 26 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 10519186

    Nucleotide hemi-sulfate salt for the treatment of hepatitis C virus

    Atea Pharmaceuticals, Inc. · Granted Tue Dec 31 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 26 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 10519222

    Broadly neutralizing monoclonal antibodies against HIV-1 V1V2 Env region

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Dec 31 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 26 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 10517942

    Polypeptide glycopeptide fragments from the V1/V2 and V3 domains of the HIV-1 envelope protein gp 120

    The Regents of the University of California · Granted Tue Dec 31 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 26 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 10513703

    Hepatitis B virus (HBV) iRNA compositions and methods of use thereof

    Alnylam Pharmaceuticals, Inc. · Granted Tue Dec 24 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 19 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 10513533

    Tunicamycin related compounds with anti-bacterial activity

    The United States of America, as represented by the Secretary of Agriculture · Granted Tue Dec 24 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 19 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 10512675

    Adeno-associated virus factor VIII vectors, associated viral particles and therapeutic formulations comprising the same

    BIOMARIN PHARMACEUTICAL INC. · Granted Tue Dec 24 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 19 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 10512673

    Use of peptide-based inhibitors of the stat3-IL10 pathway for treating bacterial infection and granulomatous disease

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Dec 24 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 19 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 10512649

    Methods and compositions for treatment of zika virus infection

    BioCryst Pharmaceuticals, Inc. · Granted Tue Dec 24 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 19 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 10507239

    V1/V2 fragments of a HIV-1 envelope glycoprotein

    The Regents of the University of California · Granted Tue Dec 17 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 12 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 10493030

    Combination HIV therapeutic

    Aphios Corporation · Granted Tue Dec 03 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 28 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 10487140

    Targeting immunological functions to the site of bacterial infections using cell wall targeting domains of bacteriolysins

    INTEGRATED BIOTHERAPEUTICS, INC. · Granted Tue Nov 26 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 21 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  21. US 10485800

    Mixed lineage kinase inhibitors for HIV/AIDS therapies

    BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Tue Nov 26 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 21 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  22. US 10479996

    Antisense antiviral compound and method for treating ss/RNA viral infection

    Sarepta Therapeutics, Inc. · Granted Tue Nov 19 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 14 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  23. US 10478485

    Methods and compositions to prevent or treat bacterial infections

    The Board of Regents of the University of Texas System · Granted Tue Nov 19 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 14 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  24. US 10442788

    Hepatitis B antiviral agents

    Enanta Pharmaceuticals, Inc. · Granted Tue Oct 15 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 10 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  25. US 10441646

    Infectious plasmodium sporozoites grown in vitro

    Sanaria Inc. · Granted Tue Oct 15 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 10 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  26. US 10441546

    Bacterially derived intact minicells that encompass plasmid free DNA and methods of using the same

    EnGeneIC Molecular Delivery Pty Ltd · Granted Tue Oct 15 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 10 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  27. US 10434116

    Methods of treating coronavirus infection

    United States Government as represented by the Secretary, Department of Health and Human Services · Granted Tue Oct 08 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 03 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  28. US 10434114

    Methods of treating a bacterial infection using a fixed-dose pharmaceutical composition comprising three antibiotics

    RedHill Biopharma Ltd. · Granted Tue Oct 08 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 03 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  29. US 10435461

    Therapy for filovirus infection

    The Government of the United States, as represented by the Secretary of the Army · Granted Tue Oct 08 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 03 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  30. US 10426736

    Delivering functional nucleic acids to mammalian cells via bacterially-derived, intact minicells

    EnGeneIC Molecular Delivery Pty Ltd · Granted Tue Oct 01 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 26 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  31. US 10428070

    Hepatitis B antiviral agents

    Enanta Pharmaceuticals, Inc. · Granted Tue Oct 01 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 26 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  32. US 10421805

    Anti-hepatitis C antibodies and antigen binding fragments thereof

    United Kingdom Research and Innovation · Granted Tue Sep 24 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 19 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  33. US 10415037

    Compositions and methods for silencing hepatitis B virus gene expression

    ARBUTUS BIOPHARMA CORPORATION · Granted Tue Sep 17 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 12 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  34. US 10413527

    Substituted phenylpyrrolecarboxamides with therapeutic activity in HIV

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Sep 17 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 12 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  35. US 10407445

    Hepatitis C virus inhibitors

    Enanta Pharmaceuticals, Inc. · Granted Tue Sep 10 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 05 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  36. US 10407414

    Mannose derivatives for treating bacterial infections

    Vertex Pharmaceuticals Incorporated · Granted Tue Sep 10 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 05 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  37. US 10398772

    Ras pathways as markers of protection against HIV and methods to improve vaccine efficacy

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Sep 03 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 29 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  38. US 10400015

    Recombinant HIV-1 envelope proteins and their use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Sep 03 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 29 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  39. US 10398682

    Methods and compositions to prevent or treat bacterial infections

    The Board of Regents of the University of Texas System · Granted Tue Sep 03 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 29 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  40. US 10391183

    Infectivity-enhanced conditionally-replicative adenovirus and uses thereof

    The Board of Regents of the University of Texas System · Granted Tue Aug 27 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 22 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  41. US 10392379

    Hepatitis B core protein modulators

    ASSEMBLY BIOSCIENCES, INC. · Granted Tue Aug 27 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 22 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  42. US 10391157

    Materials and methods for producing improved lentiviral vector particles

    IMMUNE DESIGN CORP. · Granted Tue Aug 27 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 22 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  43. US 10391098

    Antisense antibacterial compounds and methods

    The Board of Regents of the University of Texas System · Granted Tue Aug 27 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 22 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  44. US 10391075

    Antiviral treatments

    BioCryst Pharmaceuticals, Inc. · Granted Tue Aug 27 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 22 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  45. US 10383827

    Bacterially-derived, intact minicells that encompass plasmid-free functional nucleic acid for in vivo delivery to mammalian cells

    EnGeneIC Molecular Delivery Pty Ltd · Granted Tue Aug 20 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 15 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  46. US 10383830

    Modulating antibacterial immunity via bacterial membrane-coated nanoparticles

    The Regents of the University of California · Granted Tue Aug 20 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 15 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  47. US 10378014

    Compositions and methods for the treatment of influenza infection

    Lakewood Amedex, Inc. · Granted Tue Aug 13 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 08 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  48. US 10377748

    Hepatitis B core protein modulators

    ASSEMBLY BIOSCIENCES, INC. · Granted Tue Aug 13 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 08 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many Infectious disease patents are indexed?

1,492 patents match our Infectious disease classifier (title keywords in USPTO records).

Is this legal or medical advice?

No — patent intelligence is for professional reference. Verify expiration and FTO with qualified patent counsel and primary USPTO records.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.